Advantageous mu-opiate receptor peptide compounds

Details for Australian Patent Application No. 2010295996 (hide)

Owner Cytogel Pharma, LLC

Inventors Maione, Theodore E.

Agent IP Gateway Patent and Trademark Attorneys

Pub. Number AU-A-2010295996

PCT Pub. Number WO2011/034659

Priority 12/559,994 15.09.09 US

Filing date 28 July 2010

Wipo publication date 24 March 2011

International Classifications

C07K 5/12 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/034659 Priority application(s): WO2011/034659

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010296000-Elastomer composite blends, method and apparatus for producing same

2010295993-Method for creating a 3D rock representation using petrophysical data